Teleflex Incorporated (NYSE:TFX) Shares Acquired by Commerce Bank

Commerce Bank raised its position in shares of Teleflex Incorporated (NYSE:TFX) by 6.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,827 shares of the medical technology company’s stock after purchasing an additional 106 shares during the period. Commerce Bank’s holdings in Teleflex were worth $452,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Cromwell Holdings LLC boosted its position in shares of Teleflex by 59.0% during the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after buying an additional 49 shares during the period. Avior Wealth Management LLC raised its stake in Teleflex by 190.6% during the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 101 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in Teleflex during the 3rd quarter worth $40,000. GAMMA Investing LLC grew its stake in shares of Teleflex by 131.1% in the third quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock worth $42,000 after purchasing an additional 97 shares in the last quarter. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Teleflex during the second quarter valued at $42,000. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of NYSE:TFX opened at $191.02 on Wednesday. The company has a market capitalization of $8.87 billion, a PE ratio of 37.98, a price-to-earnings-growth ratio of 1.96 and a beta of 1.18. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock has a fifty day moving average of $222.95 and a 200-day moving average of $222.87. Teleflex Incorporated has a one year low of $185.66 and a one year high of $257.85.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. The business had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same quarter last year, the company posted $3.64 EPS. As a group, equities analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.71%. Teleflex’s dividend payout ratio is currently 27.04%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on TFX shares. Mizuho decreased their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Truist Financial reiterated a “hold” rating and issued a $227.00 price objective (down from $255.00) on shares of Teleflex in a report on Monday, November 4th. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. Royal Bank of Canada decreased their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Finally, Stephens lifted their price target on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, Teleflex presently has a consensus rating of “Moderate Buy” and an average price target of $259.25.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.